600C Aspheric

600C Aspheric IOL

When considering an intraocular lens, what’s important to you?

An IOL free from vacuoles and glistenings

• Single piece IOL created from Rayacryl – a homogeneous material free of microvacuoles, resulting in a glistening free IOL¹
• Compressible material for delivery through a 2.2 mm incision
• Excellent handling characteristics with controlled unfolding within the capsular bag
• Low silicone oil adherence²
• Excellent uveal biocompatibility³
• Hydrophilic acrylic material with low inflammatory response⁴

Reliable refractive outcomes and a low rate of post-operative complications

Rayner’s Anti-Vaulting Haptic (AVH) technology provides excellent fixation in the capsular bag⁵:

• Superb centration – maximum offset of only 0.4 mm 3 to 6 months after surgery¹¹
• Excellent rotational and torsional stability – 2.3° mean IOL rotation 3 to 6 months after surgery¹¹
  

  Stability of Rayner 600C Aspheric:

Medicel Viscoject 1.8 injector

Medicel Viscoject 1.8 is the world’s most frequently used universal IOL injector for use with Rayner’s 600C Aspheric lens. Viscoject implants 600C through a sub 2.2mm incision with a 1.58mm nozzle. Continuously smooth gliding properties and low injection force make Viscoject an impressive single-use injector for use with 600C.

600C Aspheric technical spec.

For Contact Ultrasound, the estimated A-constant is 118.0 Please note that the constants indicated for all Rayner lenses are estimates and are for guidance purposes only. Surgeons must always expect to personalize their own constants based on initial patient outcomes, with further personalization as the number of eyes increases.

600C Aspheric regulatory

Rayner 600C Aspheric Intraocular Lenses (IOLs)

CAUTION: Federal U.S law restricts this device to the sale by, or on the order of a physician.

INDICATIONS: The Rayner 600C intraocular lens is indicated for primary implantation for the visual correction of aphakia in adults in whom a cataractous lens has been removed by phacoemulsification. The lens is intended to be placed in the capsular bag.

CONTRAINDICATIONS: Apart from non-specific contraindications related to any form of ocular surgery, the following specific contraindications must be respected:

1. Microphthalmia
2. Active ocular disease (e.g. chronic severe uveitis, proliferative diabetic retinopathy, chronic glaucoma not responsive to medication)
3. Children under the age of 21 years
4. Corneal decompensation or corneal endothelial cell insufficiency
5. Persons who are pregnant or nursing.

WARNINGS: A risk/benefit ratio must be assessed before confirming a patient as a candidate for the Rayner 600C IOL implantation, if they are suffering from any of the following conditions:

1. Recurrent ocular disease (e.g. uveitis, diabetic retinopathy, glaucoma, corneal decompensation)
2. Previous ocular surgery
3. Non-age related cataract
4. Vitreous loss
5. Iris atrophy
6. Severe Aniseikonia
7. Ocular Hemorrhage
8. Macular degeneration
9. Zonular dehiscence
10. Ruptured posterior capsule
11. Patients in whom the intraocular lens may affect the ability to observe, diagnose, or treat posterior segment diseases.
12. Surgical difficulties at the time of cataract extraction which might increase the potential for complications (e.g. persistent bleeding, significant iris damage, uncontrolled positive pressure, or significant vitreous prolapse or loss).
13. A distorted eye due to previous trauma or developmental defect in which appropriate support of the IOL is not possible.
14. Circumstances that would result in damage to the endothelium during implantation.
15. Suspected microbial infection.
16. Children under the age of 2 years are not suitable candidates for intraocular lenses.

The Rayner 600C has optical and material equivalence to the Rayner C-flex 570C IOL.

ATTENTION: Reference the Instructions for Use labelling for a complete listing of indications and precautions.

600C Aspheric peer review papers

• Yagci R, Uzun F, Acer S, Hepsen IF. Comparison of visual quality between aspheric and spherical IOLs. Eur J Ophthalmol. 2014 Sep-Oct;24(5):688-92
• Mathew RG. & Coombes AG. Reduction of Nd:YAGCapsulotomy Rates After Implantation of a Single-Piece Acrylic Hydrophilic Intraocular Lens With 360° Squared Optic Edge: 24-Month Results. Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec;41(6):651-5
• Vyas AV, Narendran R, Bacon PJ, & Apple DJ. Three-hundred-sixty degree barrier effect of a square-edged and an enhanced-edge intraocular lens on centripetal lens epithelial cell migration Two-year results. J Cataract Refract Surg. 2007 Jan;33(1):81-7
• Werner L, Mamalis N, Pandey SK, Izak AM, Nilson CD, Davis BL, Weight C, Apple DJ. Posterior capsule opacification in rabbit eyes implanted with hydrophilic acrylic intraocular lenses with enhanced square edge. J Cataract Refract Surg. 2004 Nov;30(11):2403-9
• Tandogan T, Auffarth GU, Choi CY, Liebing S, Mayer C, Khoramnia R. In vitro comparative optical bench analysis of a spherical and aspheric optic design of the same IOL model. BMC Ophthalmol. 2017 Feb 8;17(1):9.

600C Aspheric instructions for use